KR890009889A - 피리미돈 화합물 및 그의 약학적 허용염 - Google Patents
피리미돈 화합물 및 그의 약학적 허용염 Download PDFInfo
- Publication number
- KR890009889A KR890009889A KR1019880016181A KR880016181A KR890009889A KR 890009889 A KR890009889 A KR 890009889A KR 1019880016181 A KR1019880016181 A KR 1019880016181A KR 880016181 A KR880016181 A KR 880016181A KR 890009889 A KR890009889 A KR 890009889A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- pyrimidone
- pharmaceutically acceptable
- acceptable salt
- cis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (11)
- 다음의 일반식(Ⅰ)로 표시되는 피리미돈 화합물 및 그의 약학적 허용염.일반식(Ⅰ)에서 R1,R2는 각각 탄소원자수 1 내지 12의 직쇄 또는 분지상의 알킬기 또는 다음의 일반식으로 표시되는 기 :(단 n은 1 내지 3의 정수이고 R3,R4는 각각 수소원자, 탄소원자수 1 내지 6의 알킬기, 탄소원자수 1 내지 6의 알콕시기 또는 메틸렌디옥시기) ; 그리고 A는 다음의 일반식을 가지는 기를 표시한다.(단 m 및 p는 각각 1 내지 3의 정수를 표시하고 R5내지 R8은 수소원자 또는 탄소원자수 1 내지 6의 직쇄 또는 분지상의 알킬기를 표시하거나 또는 -NR5R6및 -NR7R8은 각각기를 표시한다(단 q는 4내지 6의 정수)).
- 제1항에 있어서, R1및 R2로 표시된 탄소원자수 1 내지 12의 알킬기는 메틸, 에틸, 프로필, 이소프로필, 부틸, 이소부틸, 펜틸, 이소펜틸, 헥실, 헵틸, 옥틸, 데실 및 도데실기로 구성된 군에서 선택되고 ; R3내지 R8으로 표시된 탄소원자수 1 내지 6의 알킬기는 메틸, 에틸, 프로필, 이소프로필, 부틸, 이소부틸, 펜틸 및 이소펜틸기로 구성된 군에서 선택되고 ; 식중 치환체의 위치는 m- 또는 p-위치이고 ; 식중 기 -(CH2)p-NR7R8는 4- 또는 6-위치에 존재하는 것을 특징으로 하는 피리미돈 화합물 또는 그의 약학적 허용염.
- 제1항에 있어서, 염은 염산, 브롬화수소산, 황산, 질산, 인산, 메틸술폰산, 말레산, 푸마르산, 옥살산, 포름산 또는 아세트산의 산부가염인 것을 특징으로 하는 피리미돈 화합물 또는 그의 약학적 허용염.
- 제1항에 있어서, 화합물이 5,6-디-치환-2-[4-〈3-(1-피페리디노메틸)-페녹시〉-시스-2-부테닐아미노]-4-(1H)-피리미돈 또는 그의 약학적 혀용염인 것을 특징으로 하는 피리미돈 화합물 또는 그의 약학적 허용염.
- 제4항에 있어서, 화합물이 5,6-디메틸-2-[4-〈3-(1-피페리디노메틸)-페녹시〉-시스-2-부테닐아미노]-4-(1H)-피리미돈 염산염인 것을 특징으로 하는 피리미돈 화합물 또는 그의 약학적 허용염.
- 제4항에 있어서, 화합물이 5,6-디메틸-2-[4-〈3-(1-피페리디노메틸)-페녹시〉-시스-2-부테닐아미노]-4-(1H)-피리미돈 이염산염인 것을 특징으로 하는 피리미돈 화합물 또는 그의 약학적 허용염.
- 제1항에 있어서, 화합물이 5,6-디메틸-2-[4-〈3-(1-피페리디노메틸)-페녹시〉-시스-2-부테닐아미노]-4-(1H)-피리미돈 푸마르산염인 것을 특징으로 하는 피리미돈 화합물 또는 그의 약학적 허용염.
- 제1항에 있어서, 화합물이 5,6-디-치환-2-[4-〈4-(1-피페리디노메틸)-피리딜-2-옥시〉-시스-2-부테닐아미노]-4-(1H)-피리미돈 또는 그의 약학적 허용염인 것을 특징으로 하는 피리미돈 화합물 또는 그의 약학적 허용염.
- 제8항에 있어서, 화합물이 5,6-디메틸-2-[4-〈4-(1-피페리디노메틸)-피리딜-2-옥시〉-시스-2-부테닐아미노]-4-(1H)-피리미돈 또는 그의 약학적 허용염인 것을 특징으로 하는 피리미돈 화합물 또는 그의 약학적 허용염.
- 제9항에 있어서, 화합물이 5,6-디메틸-2-[4-〈4-(1-피페리디노메틸)-피리딜-2-옥시〉-시스-2-부테닐아미노]-4-(1H)-피리미돈 염산염인 것을 특징으로 하는 피리미돈 화합물 또는 그의 약학적 허용염.
- 제9항에 있어서, 화합물이 5,6-디메틸-2-[4-〈4-(1-피페리디노메틸)-피리딜-2-옥시〉-시스-2 -부테닐아미노]-4-(1H)-피리미돈 이염산염인 것을 특징으로 하는 피리미돈 화합물 또는 그의 약학적 허용염.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP?62-309293 | 1987-12-07 | ||
JP62309293A JPH0613486B2 (ja) | 1987-12-07 | 1987-12-07 | ピリミドン誘導体及びその医薬的に許容される塩 |
JP62-309293 | 1987-12-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR890009889A true KR890009889A (ko) | 1989-08-04 |
KR960002557B1 KR960002557B1 (ko) | 1996-02-22 |
Family
ID=17991256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019880016181A KR960002557B1 (ko) | 1987-12-07 | 1988-12-05 | 피리미돈 화합물 및 그의 약학적 허용염 |
Country Status (10)
Country | Link |
---|---|
US (1) | US4956463A (ko) |
EP (1) | EP0319903B1 (ko) |
JP (1) | JPH0613486B2 (ko) |
KR (1) | KR960002557B1 (ko) |
AT (1) | ATE110060T1 (ko) |
AU (1) | AU609229B2 (ko) |
CA (1) | CA1308717C (ko) |
DE (1) | DE3851129T2 (ko) |
DK (1) | DK169323B1 (ko) |
ES (1) | ES2058223T3 (ko) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS597177A (ja) * | 1982-07-06 | 1984-01-14 | Teikoku Hormone Mfg Co Ltd | 新規な置換ベンジルアミン誘導体 |
JO1275B1 (en) * | 1982-12-03 | 1985-04-20 | هنري براون ثوماس | Chemical process |
JPS60255756A (ja) * | 1984-06-01 | 1985-12-17 | Ikeda Mohandou:Kk | アミノアルキルフエノキシ誘導体 |
CA1275097A (en) * | 1984-10-02 | 1990-10-09 | Fujio Nohara | Pyridyloxy derivatives |
JPS61155373A (ja) * | 1984-12-28 | 1986-07-15 | Yamanouchi Pharmaceut Co Ltd | 新規な2−置換アミノ−4(1h)−ピリミドン誘導体及びその製造法 |
-
1987
- 1987-12-07 JP JP62309293A patent/JPH0613486B2/ja not_active Expired - Lifetime
-
1988
- 1988-12-05 KR KR1019880016181A patent/KR960002557B1/ko not_active IP Right Cessation
- 1988-12-06 CA CA000585089A patent/CA1308717C/en not_active Expired - Fee Related
- 1988-12-06 AU AU26563/88A patent/AU609229B2/en not_active Ceased
- 1988-12-06 EP EP88120340A patent/EP0319903B1/en not_active Expired - Lifetime
- 1988-12-06 AT AT88120340T patent/ATE110060T1/de not_active IP Right Cessation
- 1988-12-06 DE DE3851129T patent/DE3851129T2/de not_active Expired - Fee Related
- 1988-12-06 ES ES88120340T patent/ES2058223T3/es not_active Expired - Lifetime
- 1988-12-07 DK DK681688A patent/DK169323B1/da not_active IP Right Cessation
- 1988-12-07 US US07/281,040 patent/US4956463A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH01149774A (ja) | 1989-06-12 |
DK681688A (da) | 1989-06-08 |
DE3851129T2 (de) | 1994-12-01 |
KR960002557B1 (ko) | 1996-02-22 |
DE3851129D1 (de) | 1994-09-22 |
EP0319903A3 (en) | 1990-07-25 |
ES2058223T3 (es) | 1994-11-01 |
DK169323B1 (da) | 1994-10-10 |
US4956463A (en) | 1990-09-11 |
AU2656388A (en) | 1989-06-08 |
AU609229B2 (en) | 1991-04-26 |
DK681688D0 (da) | 1988-12-07 |
CA1308717C (en) | 1992-10-13 |
JPH0613486B2 (ja) | 1994-02-23 |
EP0319903B1 (en) | 1994-08-17 |
EP0319903A2 (en) | 1989-06-14 |
ATE110060T1 (de) | 1994-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR890003671A (ko) | 신규 항우울제 | |
EP0244115A3 (en) | Phenyl-piperazine anti-arrhythmia agents | |
JPS5461195A (en) | N2-substituted phenyl-2,6-diaminonebularin | |
EP0823413A3 (en) | Benzoheterocyclic compounds | |
EP0317991A3 (en) | 1-aryl-3-quinoline- and 1-aryl-3-isoquinoline-carboxamides, a process for their preparation and their use as medicaments | |
EP0353955A3 (en) | Novel compounds | |
DK0479546T3 (da) | Piperazinderivater | |
SE8800638D0 (sv) | Antihypercholesterolemic tetrazole compounds | |
US6028081A (en) | Substituted quinolone derivatives and pharmaceuticals containing the same | |
ES8801290A1 (es) | Un metodo para preparar derivados de cefem | |
DK26289A (da) | Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia | |
EP0233686A3 (en) | Bis phenyl ethanol amines and bis phenyoxypropanolamines having a beta-agonist activity | |
NO883805D0 (no) | Polymorf variant av forbindelsen 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-8-azaspiro-(4.5)dekan-7,9-dion. | |
KR890009889A (ko) | 피리미돈 화합물 및 그의 약학적 허용염 | |
EP0470686A3 (en) | (benzhydryloxyethylpiperidyl)aliphatic acid derivatives and their use in the treatment of allergies and asthma | |
EP0260655A3 (en) | Unsaturated fatty acid derivatives and their production | |
EP0205299A3 (en) | Isatin derivatives, compositions containing the same, and the use thereof for ulcer diseases | |
EP0133259A2 (en) | Aminoalkyl-substituted benzene derivatives, process for production thereof, and pharmaceutical composition thereof | |
PT85300A (fr) | Procede de preparation de nouveaux derives de la piperazine dione-2,6 | |
KR930007910A (ko) | N-메톡시페닐에틸-n'-이미다졸릴페닐아미딘 유도체 및 그의 제조방법 | |
KR950017965A (ko) | 3-(페닐알킬아미노알킬옥시)-5-페닐피라졸 화합물과 그 제조공정 그리고 제조중의 중간산물 및 이 화합물을 함유하는 의약품 | |
TW262462B (ko) | ||
JPS57116052A (en) | Quinazoline derivative and its preparation | |
KR870008887A (ko) | 방향족 ω-알킬이미노- 테트라하이드로-6H-1,3-티아진-6-온 유도체 | |
KR930007909A (ko) | N-메톡시페닐에틸-n'-이미다졸릴페닐아미딘 유도체 및 그의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |